A bold cross-industry leap and a philosophy of cognitive challenge
The appointment of Dame Emma Walmsley to lead HP Inc represents one of the most prominent leadership transitions across global enterprise markets this year. Having led pharmaceuticals giant GSK from 2017 through late 2025 following a distinguished 17-year tenure at French cosmetics company L'Oreal, Walmsley has continually shattered conventional executive boundaries.
I explicitly invite the counterview; I come across as having conviction and an opinion, which I do, but I also am quite comfortable with shifting it if the facts change.
Her executive methodology is characterized by actively encouraging colleagues to voice counterviews, ensuring leadership never remains captive to internal echo chambers. This transformative discipline was evidenced in her stewardship of GSK, culminating in the successful multibillion-dollar spinoff of consumer health enterprise Haleon and the strategic overhaul of company operations.
Her elevation within the tech sector confirms an evolving institutional reality: deep capabilities in organizational transformation increasingly supersede narrow vertical experience when managing complex multinational institutions.

















